Status:
UNKNOWN
ATTR Amyloidosis in Elderly Patients With Aortic Stenosis
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Aortic Stenosis Symptomatic
Amyloidosis Cardiac
Eligibility:
All Genders
Brief Summary
Severe aortic stenosis is defined with a mean transvalvular pressure gradient (MTPG) \> 40mmHg and a calculated aortic valve area of \< 1cm2. However, a considerable proportion of patients do have a M...
Eligibility Criteria
Inclusion
- Symptomatic, severe aortic stenosis
Exclusion
- More than mild valvular disease of any other valve
- Other severe disease with a life expectancy \< 1 year
- Participating in trial interfering with routine clinical practice or use of a non-CE marked device
Key Trial Info
Start Date :
August 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
489 Patients enrolled
Trial Details
Trial ID
NCT04061213
Start Date
August 26 2019
End Date
December 1 2022
Last Update
December 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bern - Inselspital
Bern, Canton of Bern, Switzerland, 3010